Eli Lilly & Co. is suing four telehealth companies selling compounded versions of Lilly’s weight-loss drug Zepbound and its diabetes drug Mounjaro.
Related Posts
Wholesale price measure was flat in February, compared with expected increase
The producer price index was expected to rise 0.3% in February, according to the Dow Jones consensus forecast.
JPMorgan Chase is boosting buybacks even after CEO Jamie Dimon called the stock expensive
Fresh off a record year for profit and revenue, JPMorgan is facing questions over what CFO Jeremy Barnum admitted was excess capital.
Tencent fourth-quarter profit surges 90% on gaming and advertising boost
Tencent on Wednesday posted a fourth-quarter beat on top and bottom line driven by a surge in gaming and advertising revenue.